Our BloG

March 12, 2021

Transgender Breast Cancer Risks to Be Aware Of

Breast Cancer Risk in Transgender Women

Although data on transgender women is limited, breast cancer screening guidelines in this patient population are evolving. Transgender women have a high prevalence of dense breasts, which is an independent risk for breast cancer. Transgender women differ from non-transgender women in the length of exposure to estrogens as well as variable exposure to progestogens. Therefore, it is recommended that screening not begin in transgender women until after a minimum of 5 years of feminizing hormone use, regardless of age. Some providers may choose to discuss the risks and unknowns with patients and delay screening until after up to 10 years of feminizing hormone use, regardless of age. If you are unsure about when to start screening, it is important to discuss this with your provider. Source: Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health and Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People.

You have a choice in where you receive your medical imaging. Give us a call today at 203‑426‑3002 to learn more or schedule an appointment ›